GlassScriptPhysician profile
Omar Abuqamar
NPI 1437640414
$2,686.29
in general payments reported to CMS, 2019-2025
6 companies · $904 in 2025
The $904 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.20 · 2024: $1,750 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,047 · Food and Beverage: $890 · Grant: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,046.73 |
| Food and Beverage | $889.56 |
| Grant | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,465.90 | 2024-2025 | Constellation |
| Regeneron Pharmaceuticals, INC. | $886.31 | 2024-2025 | Eylea Hd |
| Genentech USA, INC. | $127.00 | 2024 | Vabysmo |
| Abbvie INC. | $111.74 | 2024 | |
| Apellis Pharmaceuticals, INC. | $63.14 | 2024 | Syfovre |
| Glaukos Corporation | $32.20 | 2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Abuqamar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.